top of page
Tirzepatide
Dual-action weekly injection for enhanced weight loss and metabolic support.
Service Description
Tirzepatide targets both GLP-1 and GIP receptors, offering a dual mechanism to reduce appetite and enhance insulin regulation. It often produces faster or more pronounced results than Semaglutide, especially in individuals with insulin resistance or metabolic conditions. Benefits: -Dual-hormone approach for increased effectiveness -May produce more rapid weight loss results -Improves insulin sensitivity and metabolic health -Weekly dosing with medical supervision Best for: Individuals with more significant weight loss goals or those with type 2 diabetes or prediabetes.
bottom of page